Literature DB >> 28147251

Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma.

Mark Fairweather1, Jiping Wang2, Vickie Y Jo3, Elizabeth H Baldini4, Monica M Bertagnolli2, Chandrajit P Raut5.   

Abstract

BACKGROUND: The incidence of histopathologic organ invasion (HOI) in retroperitoneal sarcoma (RPS) is not well described. We reviewed our experience to investigate the rate and prognostic implications of HOI. STUDY
DESIGN: Patients with primary RPS who underwent surgery at our institution were reviewed. Histopathologic organ invasion was defined as microscopic organ invasion confirmed by re-review of pathology slides by an expert sarcoma pathologist. Impact of HOI on the crude cumulative incidence of locoregional recurrence, distant recurrence, and overall survival rates was analyzed.
RESULTS: Between 2002 and 2011, one hundred and eighteen patients underwent resection for primary RPS; 99 had at least 1 organ resected and, among those, HOI was present in 58% (57 of 99). Among the 77 patients with the 3 most common histologies, rates of HOI were 61% for dedifferentiated liposarcoma, 56% for leiomyosarcoma, and 40% for well-differentiated liposarcoma. In this subset, HOI was associated with no difference in 2-year crude cumulative incidence of locoregional recurrence (48% vs 47%; p = 0.55) or distant recurrence (46% vs 22%; p = 0.2). With a median follow-up of 33.6 months, HOI was an independent predictor of worse 5-year overall survival (34% vs 62%; p = 0.04; hazard ratio = 2.3; 95% CI 1.2 to 4.4; p = 0.02).
CONCLUSIONS: The likelihood of organ invasion can be predicted by histologic subtype of primary RPS. To the best of our knowledge, this is the first study to demonstrate that HOI is associated with worse overall survival. These data can help guide the minimal extent of surgical resection required for RPS.
Copyright © 2017 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28147251     DOI: 10.1016/j.jamcollsurg.2017.01.044

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

1.  Retroperitoneal Sarcomas: Prognostic Factors and Outcomes of a Series of Patients Treated at a Single Institution.

Authors:  Shraddha Patkar; Abhay K Kattepur; Rajesh Shinde; Mahesh Goel
Journal:  Indian J Surg Oncol       Date:  2020-01-15

Review 2.  Tumor Biological Aspects of Epithelial versus Mesenchymal Tumors of the Gastrointestinal Tract.

Authors:  Chandrajit P Raut
Journal:  Visc Med       Date:  2018-10-28

Review 3.  Retroperitoneal Sarcomas: a Current Review on Management.

Authors:  Shraddha Patkar; Abhay K Kattepur; Nehal Khanna; Jyoti Bajpai
Journal:  Indian J Surg Oncol       Date:  2022-02-21

Review 4.  Landmark Series: A Review of Landmark Studies in the Treatment of Primary Localized Retroperitoneal Sarcoma.

Authors:  Megan Delisle; David Gyorki; Sylvie Bonvalot; Carolyn Nessim
Journal:  Ann Surg Oncol       Date:  2022-09-10       Impact factor: 4.339

5.  Postoperative Outcomes of Distal Pancreatectomy for Retroperitoneal Sarcoma Abutting the Pancreas in the Left Upper Quadrant.

Authors:  Kyeong Deok Kim; Kyo Won Lee; Ji Eun Lee; Jeong Ah Hwang; Sung Jun Jo; Jinseob Kim; So Hee Lim; Jae Berm Park
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

6.  Prognostic implications of histological organ involvement in retroperitoneal sarcoma.

Authors:  R Tyler; M Lee; V Ierodiakonou; J Hodson; P Taniere; M Almond; S Ford; A Desai
Journal:  BJS Open       Date:  2021-09-06

Review 7.  Surgical Principles of Primary Retroperitoneal Sarcoma in the Era of Personalized Treatment: A Review of the Frontline Extended Surgery.

Authors:  Paula Munoz; Pedro Bretcha-Boix; Vicente Artigas; José Manuel Asencio
Journal:  Cancers (Basel)       Date:  2022-08-24       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.